KENS 5: Weekend walk in SA will honor those who battled oral cancer. Here’s how to register.
October 13, 2023
The UT Health San Antonio School of Dentistry and Oral Cancer Foundation is mentioned in this news segment. Watch Now
October 13, 2023
The UT Health San Antonio School of Dentistry and Oral Cancer Foundation is mentioned in this news segment. Watch Now
October 9, 2023
Weixing Zhao, PhD, and Sandeep Burma, PhD, both with the Department of Biochemistry and Structural Biology and the UT Health San Antonio Mays Cancer Center, were quoted in this article. Read More
October 6, 2023
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto is a novel targeted molecular therapy that delivers radiation treatment […]
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. Read More
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. Read More
October 6, 2023
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women. The […]